Accéder au contenu
Merck

Lessons in biology from patients with inborn errors of vitamin B12 metabolism.

Biochimie (2013-02-14)
David Watkins, David S Rosenblatt
RÉSUMÉ

Since 1975 cells lines from patients with suspected inborn errors of vitamin B12 metabolism have been referred to our laboratory because of elevations of homocysteine, methylmalonic acid, or both. Cultured fibroblasts from patients were subjected to a battery of tests: incorporation of labelled propionate and methyltetrahydrofolate into cellular macromolecules, to test the functional integrity of methylmalonyl-CoA mutase and methionine synthase, respectively; uptake of labelled cyanocobalamin and synthesis of adenosylcobalamin and methylcobalamin; and, where applicable, complementation analysis. This approach has allowed for the discovery of novel steps in the cellular transport and metabolism of vitamin B12, including those involving cellular uptake, the efflux of vitamin B12 from lysosomes, and the synthesis of adenosylcobalamin and methylcobalamin. For all of these disorders, the responsible genes have been discovered. The study of highly selected patients with suspected inborn errors of metabolism has consistently resulted in the discovery of previously unknown metabolic steps and has provided new lessons in biology.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Vitamine B12, ≥98%
Sigma-Aldrich
Vitamine B12, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Supelco
Cyanocobalamin (B12), analytical standard
Supelco
Vitamine B12, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Vitamine B12, pharmaceutical secondary standard, certified reference material
Sigma-Aldrich
Vitamine B12, meets USP testing specifications
Vitamine B12, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Vitamine B12, tested according to Ph. Eur.